4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-044885
President and COO sold 20,549 shares at $17.99 ($369,677)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McNeill Jonathan President and COO | 2026-06-22 | Sale 10b5-1 | −20,549 | $17.99 | $369,677 | 139,158 | D |
| Open-market sales · 20,549 sh · avg $17.99 · $369,677 | |||||||
Loading xslF345X06/wk-form4_1782244938.xml…